InsidersTradesSigma
National Instruments CORP Stock: price and directors' dealings · United States · SEC (Form 4)
Track the National Instruments CORP share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Technology sector, National Instruments CORP has published 119 public disclosures. The latest transaction was disclosed on 11 October 2023 (Disposition). Among the most active insiders: Rust Scott Arthur. Every trade is free.
119
Insider Decl.
0
Thresholds
€147,054
2 ops.
Buy Volume
€8m
46 ops.
Sell Volume
32Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 October 2023
Declarations119 total
121,775 sharesCommon StockSEC:0001140361-23-047925:0
21,501 sharesCommon StockSEC:0001140361-23-047924:0
150 sharesCommon StockSEC:0001140361-23-047918:0
27,919 sharesCommon StockSEC:0001140361-23-047917:0
248,908 sharesCommon StockSEC:0001140361-23-047928:0
18,560 sharesCommon StockSEC:0001140361-23-047921:0
47,092 sharesCommon StockSEC:0001140361-23-047926:0
21,501 sharesCommon StockSEC:0001140361-23-047919:0
10,477 sharesCommon StockSEC:0001140361-23-047922:0
28,573 sharesCommon StockSEC:0001140361-23-047923:0
16,937 sharesCommon StockSEC:0001140361-23-047927:0
184,813 sharesCommon StockSEC:0001140361-23-047920:0
5,025 shares@ US$59.0070.2% of flowCommon StockSEC:0000935494-23-000071:0
3,494 shares@ US$57.7014.6% of flowCommon StockSEC:0000935494-23-000062:0
29,821 shares@ US$57.97562.5% of flowCommon StockSEC:0000935494-23-000060:0
5,037 shares@ US$58.05530.0% of flowCommon StockSEC:0000935494-23-000058:0
150 shares@ US$45.901.1% of flowCommon StockSEC:0000935494-23-000045:0
124 shares@ US$45.900.2% of flowCommon StockSEC:0000935494-23-000047:0
9,479 sharesCommon StockSEC:0000935494-23-000049:0
503 shares@ US$58.2311.3% of flowCommon StockSEC:0000935494-23-000051:0
2,155 shares@ US$58.2329.8% of flowCommon StockSEC:0000935494-23-000038:0
7,852 shares@ US$58.2332.4% of flowCommon StockSEC:0000935494-23-000041:0
3,719 shares0Common StockSEC:0000935494-23-000024:0
3,719 shares0Common StockSEC:0000935494-23-000028:0
3,719 shares0Common StockSEC:0000935494-23-000020:0
25 of 119 declarations
About National Instruments CORP
From a market-positioning standpoint, NI has long been viewed as a premium brand in automated test because of its integrated ecosystem and strong engineering credibility. Emerson stated that NI served about 35,000 customers and generated $1.66 billion of revenue in 2022, highlighting the scale of the platform before integration. Recent developments have centered on Emerson’s continued investment in NI’s roadmap: in 2024 Emerson reaffirmed support for core NI products such as LabVIEW and TestStand and showcased AI-related enhancements at NI Connect. For investors, NATI should therefore be understood as a specialized technology franchise, now part of Emerson, with exposure to secular demand for intelligent test automation, product validation, and digital manufacturing workflows in the United States and globally.
